PureTech Health ( (GB:PRTC) ) just unveiled an announcement.
PureTech Health announced its participation in the upcoming Leerink Partners Global Healthcare Conference, where key executives will engage in a fireside chat. This event underscores PureTech’s active role in the healthcare industry, potentially enhancing its visibility and influence among stakeholders and investors.
More about PureTech Health
PureTech Health is a clinical-stage biotherapeutics company focused on developing new classes of medicine to treat devastating diseases. The company has a robust pipeline of 29 therapeutics and therapeutic candidates, with three already approved by the U.S. Food and Drug Administration. PureTech advances its programs through its own efforts and through its Founded Entities, leveraging its extensive network of scientists, clinicians, and industry leaders.
YTD Price Performance: -5.86%
Average Trading Volume: 593,608
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £338.5M
For detailed information about PRTC stock, go to TipRanks’ Stock Analysis page.